Depletion of host reactive T cells by photodynamic cell purging and prevention of graft versus host disease

被引:10
作者
Goggins, TF [1 ]
Chao, N [1 ]
机构
[1] Duke Univ, Med Ctr, Durham, NC 27710 USA
关键词
photodynamic cell purging; GVHD; depletion of reactive T cells; graft versus host disease;
D O I
10.1080/1042819031000119226
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Graft versus Host Disease (GVHD) is the principal cause of morbidity and mortality in patients undergoing allogeneic stem cell transplant. T cell depletion has been recognized as a method of reducing the incidence of GVHD in allogeneic transplants. Until recently, most T cell depletion methods were non-selective in reducing lymphocytes. Rhodamine purging is one method, which selectively reduces alloreactive T cells preventing GVHD. We review here the methods of non-selective and selective T cell depletion, particularly the newer method of photodynamic purging utilizing rhodamine.
引用
收藏
页码:1871 / 1879
页数:9
相关论文
共 126 条
[21]  
CHAUDHARY PM, 1992, BLOOD, V80, P2735
[22]   Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process [J].
Chen, BJ ;
Cui, XY ;
Liu, CX ;
Chao, NJ .
BLOOD, 2002, 99 (09) :3083-3088
[23]   Prevention of graft-versus-host disease in mice using a suicide gene expressed in T lymphocytes [J].
Cohen, JL ;
Boyer, O ;
Salomon, B ;
Onclercq, R ;
Charlotte, F ;
Bruel, S ;
Boisserie, G ;
Klatzmann, D .
BLOOD, 1997, 89 (12) :4636-4645
[24]   Suicide gene therapy of graft-versus-host disease: immune reconstitution with transplanted mature T cells [J].
Cohen, JL ;
Boyer, O ;
Klatzmann, D .
BLOOD, 2001, 98 (07) :2071-2076
[25]   MULTIDRUG RESISTANCE ACTIVITY IN HUMAN-LYMPHOCYTES [J].
COON, JS ;
WANG, YZ ;
BINES, SD ;
MARKHAM, PN ;
CHONG, ASF ;
GEBEL, HM .
HUMAN IMMUNOLOGY, 1991, 32 (02) :134-140
[26]  
DADMARZ R, 1995, CANCER IMMUNOL IMMUN, V40, P1
[27]   Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: A prospective, randomized trial [J].
Deeg, HJ ;
Lin, DY ;
Leisenring, W ;
Boeckh, M ;
Anasetti, C ;
Appelbaum, FR ;
Chauncey, TR ;
Doney, K ;
Flowers, M ;
Martin, P ;
Nash, R ;
Schoch, G ;
Sullivan, KM ;
Witherspoon, RP ;
Storb, R .
BLOOD, 1997, 89 (10) :3880-3887
[28]  
DEEG HJ, 1990, EXP HEMATOL, V18, P916
[29]   Prevention of graft-versus-host disease by induction of immune tolerance with ultraviolet B-irradiated leukocytes in H-2 disparate bone marrow donor [J].
del Rosario, MLU ;
Zucali, JR ;
Kao, KJ .
BLOOD, 1999, 93 (10) :3558-3564
[30]   BONE-MARROW REPOPULATION CAPACITY AFTER TRANSPLANTATION OF LYMPHOCYTE-DEPLETED ALLOGENEIC BONE-MARROW USING COUNTERFLOW CENTRIFUGATION [J].
DEWITTE, T ;
RAYMAKERS, R ;
PLAS, A ;
KOEKMAN, E ;
WESSELS, H ;
HAANEN, C .
TRANSPLANTATION, 1984, 37 (02) :151-155